Search Images Maps Play YouTube News Gmail Drive More »
Sign in
Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader.

Patents

  1. Advanced Patent Search
Publication numberUS20070049501 A1
Publication typeApplication
Application numberUS 11/217,955
Publication dateMar 1, 2007
Filing dateSep 1, 2005
Priority dateSep 1, 2005
Also published asUS7795186, US20090258801, WO2007026144A1
Publication number11217955, 217955, US 2007/0049501 A1, US 2007/049501 A1, US 20070049501 A1, US 20070049501A1, US 2007049501 A1, US 2007049501A1, US-A1-20070049501, US-A1-2007049501, US2007/0049501A1, US2007/049501A1, US20070049501 A1, US20070049501A1, US2007049501 A1, US2007049501A1
InventorsRajesh Saini, Karen Savery
Original AssigneeHalliburton Energy Services, Inc.
Export CitationBiBTeX, EndNote, RefMan
External Links: USPTO, USPTO Assignment, Espacenet
Fluid-loss control pills comprising breakers that comprise orthoesters and/or poly(orthoesters) and methods of use
US 20070049501 A1
Abstract
Provided herein are methods and compositions for generating acids for use downhole, for example, to break fluid-loss control pills. The delayed-release acid breakers of the present invention comprise orthoesters and/or poly(orthoesters).
Images(7)
Previous page
Next page
Claims(20)
1. A method comprising:
providing a fluid-loss control pill that comprises an aqueous base fluid and a gelling agent, and a delayed-release acid breaker that comprises an orthoester and/or a poly(orthoester);
introducing the fluid-loss control pill and the delayed-release acid breaker into a subterranean formation;
allowing the delayed-release acid breaker to generate an acid after a delay period; and
allowing the fluid-loss control pill to break.
2. The method of claim 1 wherein the orthoester has the general formula RC(OR′)(OR″)(OR′″), wherein R′, R″, and R′″ are not hydrogen, and R′, R″, and R′″ may or may not be the same group.
3. The method of claim 2 wherein R′, R″, or R′″ comprise a heteroatom.
4. The method of claim 1 wherein the gelling agent comprises a polymer selected from the group consisting of: a natural polymer; a synthetic polymer; xanthan; a xanthan derivative; guar; a guar derivative; cellulose; a cellulose derivative; carboxymethylhydroxyethyl cellulose; hydroxyethyl cellulose; a graft copolymer of hydroxyethyl or hydroxypropyl cellulose prepared by a redox reaction with vinyl phosphonic acid monomers or polymers; polyacrylate; polymethacrylate; polyamylamide; polyvinyl alcohol; polyvinylpyrolidone; a depolymerized gelling agent; derivatives thereof; and combinations thereof.
5. The method of claim 1 wherein the orthoester is an orthoacetate; an orthoformate; an orthopropionate; or an orthoester of a polyfunctional alcohol.
6. The method of claim 1 wherein the poly(orthoester) is a poly(orthoacetate); a poly(orthoformate); or a poly(orthopropionate).
7. The method of claim 1 wherein the gelling agent comprises a crosslinked gelling agent that has been crosslinked in a crosslinking reaction that comprises a crosslinking agent.
8. The method of claim 7 wherein the crosslinking agent is a crosslinking agent that comprises a polyvalent metal ion; a Lewis base; a Bronsted-Lowrey base; boron; titanium; or zirconium.
9. The method of claim 1 wherein the fluid-loss control pill comprises an additive selected from the group consisting of: propylene glycol; a gel stabilizer; a clay fixer; a bridging particulate; a surfactant; a corrosion inhibitor; a biocide; a pH control additive; an oxidizer; an encapsulated breaker; and a weighting agent.
10. A fluid-loss control pill base gel that comprises a delayed-acid release breaker that comprises an orthoester and/or a poly(orthoester).
11. The delayed-release acid breaker of claim 10 wherein the orthoester or the poly(orthoester) is in a solution form, an emulsion form, a solid form, or a gel form.
12. The method of claim 10 wherein the orthoester has the general formula RC(OR′)(OR″)(OR′″), wherein R′, R″, and R′″ are not hydrogen, and R′, R″, and R′″ may or may not be the same group.
13. The method of claim 10 wherein the orthoester is an orthoacetate; an orthoformate; an orthopropionate; or an orthoester of a polyfunctional alcohol.
14. The method of claim 10 wherein the poly(orthoester) is one of the following group: a poly(orthoacetate); a poly(orthoformate); or a poly(orthopropionate).
15. A method comprising:
providing a delayed-release acid breaker that comprises an orthoester and/or a poly(orthoester), and a fluid-loss control pill base gel having a pH below about 8;
forming a first emulsion that comprises the delayed-release acid breaker and water;
adding the first emulsion to the fluid-loss control pill base gel to form a second emulsion having a continuous phase and a discontinuous phase, the discontinuous phase comprising the delayed-release acid breaker and the continuous phase comprising the fluid-loss control pill base gel; and
introducing the second emulsion into a subterranean formation.
16. The method of claim 15 wherein the fluid-loss control pill base gel comprises at least one of the following group: propylene glycol; a gel stabilizer; a clay fixer; a bridging particulate; a surfactant; a corrosion inhibitor; a biocide; a pH control additive; an oxidizer; an encapsulated breaker; a weighting agent; fresh water; salt water;
a brine; a zinc chloride brine; an ammonium chloride brine; seawater; a sodium chloride brine; a potassium chloride brine; a calcium chloride brine; a sodium bromide brine; a calcium bromide brine; and a zinc bromide brine.
17. The method of claim 15 wherein the orthoester has the general formula RC(OR′)(OR″)(OR′″), wherein R′, R″, and R′″ are not hydrogen, and R′, R″, and R′″ may or may not be the same group.
18. The method of claim 15 wherein the orthoester is an orthoacetate; an orthoformate; an orthopropionate; or an orthoester of a polyfunctional alcohol.
19. The method of claim 15 wherein the poly(orthoester) is a poly(orthoacetate); a poly(orthoformate); or a poly(orthopropionate).
20. The method of claim 15 wherein the gelling agent is a natural polymer; a synthetic polymer; xanthan; a xanthan derivative; guar; a guar derivative; cellulose; a cellulose derivative; carboxymethylhydroxyethyl cellulose; hydroxyethyl cellulose; a graft copolymer of hydroxyethyl or hydroxypropyl cellulose prepared by a redox reaction with vinyl phosphonic acid monomers or polymers; polyacrylate; polymethacrylate; polyamylamide; polyvinyl alcohol; polyvinylpyrolidone; a depolymerized gelling agent; derivatives thereof; or combinations thereof.
Description
    BACKGROUND OF THE INVENTION
  • [0001]
    The present invention relates to methods and compositions for treating subterranean formations, and more specifically, to self-destructing fluid-loss control pills for fluid-loss control in drilling, completion, and stimulation applications and their associated methods. “Fluid loss” refers to the undesirable migration or loss of fluids (such as the fluid portion of a drilling mud or cement slurry) into a subterranean formation.
  • [0002]
    Providing effective fluid-loss control for well treatment fluids is highly desirable. A “well treatment fluid” is a fluid used in a subterranean application. The term “treatment” herein does not imply any particular action by the fluid or any component thereof. Fluid-loss control materials are additives specifically designed to lower the volume of a filtrate that passes through a filter medium. Most attain their fluid-loss control from the presence of solvent-specific solids, or from hydrated linear polymers that rely on filter cake backup and on viscoelasticity to inhibit flow into and through the formation. A variety of fluid-loss control materials have been used and evaluated, including foams, oil-soluble resins, acid-soluble particulates, graded salt slurries, linear viscoelastic polymers, and heavy metal-crosslinked polymers. Their respective comparative effects are well documented. Other techniques that have been developed to control fluid loss include the use of “fluid-loss control pills,” which sometimes are referred to as “lost circulation pills.” A “fluid-loss control pill” is a gelled fluid that is designed or used to provide some degree of fluid-loss control. Through a combination of viscosity, solids bridging, and cake buildup on the porous rock, these pills oftentimes are able to substantially seal off portions of the formation from fluid loss. They also generally enhance filter-cake buildup on the face of the formation to inhibit fluid flow into the formation from the well bore.
  • [0003]
    Typically, fluid-loss control pills comprise an aqueous base fluid and a high concentration of a gelling agent polymer (usually crosslinked), and sometimes, bridging particles, like graded sand, potassium salts, or sized calcium carbonate particles. The term “gel,” as used herein, and its derivatives refers to a semi-solid, jelly-like state assumed by some colloidal dispersions. The most commonly used fluid-loss control pills contain high concentrations (100 to 150 lbs/1000 gal) of hydroxyethylcellulose (“HEC”). HEC is generally accepted as a gelling agent affording minimal permeability damage during completion operations. Normally, HEC polymer solutions do not form rigid gels, but control fluid loss by a viscosity-regulated or filtration mechanism. Some other gelling agent polymers that have been used include guar, guar derivatives, carboxymethylhydroxyethylcellulose (“CMHEC”), and even starch.
  • [0004]
    As an alternative to linear polymeric gels for fluid-loss control pills, crosslinked gels often are used. Crosslinking the gelling agent polymer creates a gel structure that can support solids as well as provide fluid-loss control. Further, crosslinked fluid-loss control pills have demonstrated that they require relatively limited invasion of the formation face to be fully effective. To crosslink the gelling agent polymers, a suitable crosslinking agent that comprises polyvalent metal ions is used. Aluminum, titanium, and zirconium are common examples.
  • [0005]
    A preferred crosslinkable gelling agent for fluid-loss control pills are graft copolymers of a hydroxyalkyl cellulose, guar, or hydroxypropyl guar that are prepared by a redox reaction with vinyl phosphonic acid. The gel is formed by hydrating the graft copolymer in an aqueous fluid containing at least a trace amount of at least one divalent cation. The gel is crosslinked by the addition of a Lewis base or Bronsted-Lowrey base so that pH of the fluid is adjusted from slightly acidic to slightly basic. Preferably, the chosen base is substantially free of polyvalent metal ions. The resulting crosslinked gel demonstrates shear-thinning and rehealing properties that provide relatively easy pumping, while the rehealed gel provides good fluid-loss control upon placement. This gel can be broken by reducing the pH of the fluid. Some fluid-loss pills of this type are described in U.S. Pat. No. 5,304,620, assigned to Halliburton Energy Sources, the relevant disclosure of which is incorporated herein by reference. Fluid-loss control pills of this type are commercially available under the trade name “K-MAX” from Halliburton Energy Services in Duncan, Okla.
  • [0006]
    After their application, fluid-loss control pills can cause severe damage to near-well bore areas due to polymer filtration or filter-cake formation. At some point in the completion operation, the filter cake resulting from a fluid-loss control pill must be removed to restore the formation's permeability, preferably to at least its original level. If the formation permeability is not restored to its original level, production levels can be significantly reduced.
  • [0007]
    Polymer-based fluid-loss control pills often require long cleanup periods. Moreover, an effective cleanup usually requires fluid circulation to provide high driving force, which allows diffusion to take place to help dissolve the concentrated build up of materials. Such fluid circulation may not be feasible. Additionally, in lower temperature wells (i.e., those below about 80 F.), it is often difficult to find an internal breaker for the fluid-loss control pills that will work effectively. Although conventional breakers (both internal and external) tend to work very quickly, usually within hours, they often do not provide predictable breaks, and thus there is little control over the break. As a result, secondary precipitation materials may result that may be damaging to the formation. The term “break” (and its derivatives) as used herein refers to a reduction in the viscosity of the fluid-loss control pill, e.g., by the breaking or reversing of the crosslinks between polymer molecules, or some breaking of the gelling agent polymers. No particular mechanism is implied by the term. Another conventional method of cleaning up a fluid-loss control pill is to add a spot of a strong acid (e.g., 10% to 15% hydrochloric acid) with coiled tubing, which is expensive and can result in hazardous conditions.
  • SUMMARY OF THE INVENTION
  • [0008]
    The present invention relates to methods and compositions for treating subterranean formations, and more specifically, to self-destructing fluid-loss control pills for fluid-loss control in drilling, completion, and stimulation applications, and their associated methods.
  • [0009]
    One embodiment of the present invention provides a method comprising: providing a fluid-loss control pill that comprises an aqueous base fluid and a gelling agent, and a delayed-release acid breaker that comprises an orthoester and/or a poly(orthoester); introducing the fluid-loss control pill and the delayed-release acid breaker into a subterranean formation; allowing the delayed-release acid breaker to generate an acid after a delay period; and allowing the fluid-loss control pill to break.
  • [0010]
    Another embodiment of the present invention provides a fluid-loss control pill base gel that comprises a delayed-acid release breaker that comprises an orthoester and/or a poly(orthoester).
  • [0011]
    Another embodiment of the present invention provides a method comprising: providing a delayed-release acid breaker that comprises an orthoester and/or a poly(orthoester), and a fluid-loss control pill base gel having a pH below about 8; forming a first emulsion that comprises the delayed-release acid breaker and water; adding the first emulsion to the fluid-loss control pill base gel to form a second emulsion having a continuous phase and a discontinuous phase, the discontinuous phase comprising the delayed-release acid breaker and the continuous phase comprising the fluid-loss control pill base gel; and introducing the second emulsion into a subterranean formation.
  • [0012]
    The features and advantages of the present invention will be apparent to those skilled in the art. While numerous changes may be made by those skilled in the art, such changes are within the spirit of the invention.
  • DESCRIPTION OF PREFERRED EMBODIMENTS
  • [0013]
    The present invention relates to methods and compositions for treating subterranean formations, and more specifically, to self-destructing fluid-loss control pills for fluid-loss control in drilling, completion, and stimulation applications, and their associated methods.
  • [0014]
    One of the many advantages of the present invention is that the breaking of the fluid-loss control pills of this invention can be delayed for a desired delay period (e.g., days or even weeks). On the other hand, degradation of the fluid-loss pills can occur relatively quickly and predictably if necessary, without the need for external intervention, such as from coiled tubing trips or acid spotting. In certain embodiments, this invention provides methods of combining the delayed-release acid breakers of the invention with a fluid-loss control pill base gel at a low pH (i.e., a pH of less than about 8) for introduction to a subterranean formation. The term “base gel” as used herein refers to a point in time before the gel is crosslinked, to form a crosslinked fluid loss control pill and/or the pH is raised such that the base gel is able to be crosslinked to form a pill. In certain embodiments, the delayed-release acid breakers of this invention may be incorporated within the fluid-loss control pill base gel in a manner so as to delay degradation of the fluid-loss control pill.
  • [0015]
    The self-destructing fluid-loss control pills of the present invention comprise an aqueous base fluid, a gelling agent, and a delayed-release acid breaker. In some embodiments, the gelling agent may be crosslinked; in others it may not. This may depend on the particular gelling agent used (e.g., a lower molecular weight gelling agent v.s. a higher molecular weight gelling agent) and the concentration of gelling agent used. It may be preferred to use a crosslinked gelling agent because less gelling agent should be used, which may translate to less of the breaker being needed, and less residue being produced upon breaking. In some embodiments, the gelling agent may not be initially crosslinked, but may crosslink downhole (e.g., during pumping) with an appropriate crosslinking agent. Preferably, the gelling agent is crosslinked before the pill is placed in the subterranean formation (e.g., before pumping or during pumping).
  • [0016]
    Optionally, the self-destructing fluid-loss control pills of the present invention may comprise propylene glycol (as an antifreeze agent); gel stabilizers (e.g., for use at higher temperatures such as those about 225 F.); clay fixers; bridging particulates (degradable or nondegradable); surfactants; corrosion inhibitors; biocides; pH control additives; oxidizers; encapsulated breakers; weighting agents (e.g., hematite, barite, or calcium carbonate); or any other additives that are suitable for use in conjunction with the self-destructing fluid-loss control pills of the present invention, which may be recognized by one of ordinary skill in the art with the benefit of this disclosure.
  • [0017]
    Suitable aqueous base fluids include fresh water, salt water, brines, seawater, or any other aqueous liquid that does not adversely react with the other components used in accordance with this invention or with the subterranean formation. Aqueous base fluids that are commonly used in oilfield operations usually include sodium chloride brines, potassium chloride brines, calcium chloride brines, zinc chloride brines, ammonium chloride brines, sodium bromide brines, calcium bromide brines, zinc bromide brines, or some mixture of these components. Such brines may be used to weight the fluid, inhibit the swelling of clays present in the subterranean formation, or the like. Monovalent and divalent brines are preferred for use in the present invention. One should note that in some fluid-loss control pills (such as hydroxyethylcellulose low pH pills), divalent brines may present a crosslinking problem at higher pHs.
  • [0018]
    Although noncrosslinked gelling agents may be used, crosslinked gelling agents are preferred, as discussed above. The term “crosslinked gelling agent,” as used herein, refers to a gelling agent that has at least one crosslink between its molecules. These gelling agents may be crosslinked by any suitable crosslinking agent and methodology. Suitable crosslinking agents include those that comprise polyvalent metal ions, a Lewis base, a Bronsted-Lowrey base, boron, titanium, zirconium, and the like. Examples of gelling agents that may be used in the present invention include any crosslinked natural polymer, synthetic polymer, derivatives thereof, or combinations thereof that are suitable for use in a subterranean application. The particular crosslinking agent chosen will depend on, among other things, the gelling agent used, the pH of the fluid-loss control pill, the pH of the environment in which the fluid-loss control pill will be used, and the like. It is preferable if the gelling agent crosslinks slowly as it is being pumped to a desired portion of a subterranean formation. Although not necessary, this slow crosslinking is preferred because of pumping and friction pressure considerations. Examples of suitable gelling agents that may or may not be crosslinked, depending on the factors discussed above, include, but are not limited to: xanthan, xanthan derivatives, guar, guar derivatives (such as hydroxypropyl guar, caraboxymethyl guar, and carboxymethylhydroxypropyl guar), cellulose and cellulose derivatives (such as hydroxyethyl cellulose, and carboxymethyethyl cellulose). Cellulose derivatives are preferred because they are capable of viscosifying a brine without the need for special rig equipment or shear devices. Preferred cellulose derivatives are either anionic or nonionic, most preferably anionic modified or nonionic modified cellulose. Carboxymethylhydroxyethyl cellulose (“CMHEC”) and hydroxyethyl cellulose (“HEC”) are examples of preferred cellulose derivatives. Another particularly preferred cellulose derivative is a graft copolymer of hydroxyethyl or hydroxypropyl cellulose prepared by a redox reaction with vinyl phosphonic acid monomers or polymers. The cellulose derivatives are preferred because 90% or greater regain permeability can be achieved after the fluid-loss control pill breaks. Examples of suitable synthetic polymers include, but are not limited to, polyacrylate, polymethacrylate, polyacrylamide, polyvinyl alcohol, and polyvinylpyrrolidone. In some embodiments, the gelling agent may be depolymerized. The term “depolymerized,” as used herein, generally refers to a decrease in the molecular weight of the gelling agent. Depolymerized gelling agents are described in U.S. Pat. No. 6,488,091 issued Dec. 3, 2002 to Weaver, et al., the relevant disclosure of which is incorporated herein by reference. In some embodiments, a base gel may be prepared by dissolving at least one of the above mentioned gelling agents in an amount of from about 10 to about 175 pounds per 1000 gallons of the fluid. Suitable crosslinked gelling agents generally are present in an amount in the range of from about 10 to about 40 pounds per 1000 gallons of base gel.
  • [0019]
    The fluid-loss control pill may be broken (i.e., its viscosity may be reduced) by lowering the pH of the fluid by addition of a delayed-release acid breaker of the present invention. The delayed-release acid breakers of the present invention comprise orthoesters and/or poly(orthoesters), which will generate an acid downhole in a delayed fashion that will break the fluid-loss control pills. This delay period may vary, and can be controlled from days or even weeks, if desired. In preferred embodiments, the desired delay period may be from days to about two weeks.
  • [0020]
    Examples of suitable orthoesters for use in the delayed-release acid breakers of the present invention have a structure described by the formula: RC(OR′)(OR″)(OR′″), wherein R′, R″, and R′″ are not hydrogen, and R′, R″, and R′″ may or may not be the same group. R′, R″, or R′″ may comprise a heteroatom that may affect the solubility of the chosen orthoester in a given application. Suitable heteroatoms could include nitrogen or oxygen. Suitable poly(orthoesters) also are described in an article entitled, Poly(orthoesters)—From Concept to Reality, BIOMACROMOLECULES, Vol 5, 1625 (2004), and references cited therein. Examples of suitable orthoesters and poly(orthoesters) include, but are not limited to, orthoacetates, such as trimethyl orthoacetate, triethyl orthoacetate, tripropyl orthoacetate, triisopropyl orthoacetate, tributyl orthoacetates, and poly(orthoacetates); orthoformates, such as trimethyl orthoformate, triethyl orthoformate, tripropyl orthoformate, triisopropyl orthoformate, tributyl orthoformate, and poly(orthoformates); and orthopropionates, such as trimethyl orthopropionate, triethyl orthopropionate, tripropyl orthopropionate, triisopropyl orthopropionate, tributyl orthopropionate, and poly(orthopropionates). Suitable orthoesters also may be orthoesters of polyfunctional alcohols, such as glycerin and/or ethylene glycol. Those skilled in the art with the benefit of this disclosure will recognize suitable orthoesters and/or poly(orthoesters) that may be used in a desired application. In choosing an orthoester, one should be mindful that some orthoesters have low flash points. Various derivatives of those orthoesters can be synthesized by transesterification with variety of alcohols, sugars, or polyols. One should be mindful that to synthesize these molecules, there should not be any free alcohol groups left after the synthesis, which can further transesterify and possibly break the molecule. Depending on the desired application, the orthoesters or the poly(orthoesters) may be water soluble, water insoluble, or solid. Generally speaking, water soluble orthoesters are easy to hydrolyze at lower temperature in comparison to water insoluble orthoesters. By making an orthoester or a poly(orthoester) more hydrophobic, the orthoester may be more suitable for use in higher temperature applications. Also, poly(orthoesters) made by glycerol and trimethyl orthoformate are water soluble depending on the number of repeating units and can be used for lower temperature applications. One of the advantages of having a poly(orthoester) over an orthoester is that it has a higher flash point and a higher viscosity. Similarly, hydrophobic poly(orthoesters) may be synthesized, which are suitable for higher temperature applications. The choice of which particular orthoester to use should be guided by such considerations as environmental factors, and the desired delay time before a sufficient amount of acid is generated to break the fluid-loss control pill. One should also note that orthoesters and polyorthoesters can be selected to either give you formic or acetic acid on hydrolysis. For applications adjacent to acid-sensitive zones, weaker acids, such as formic and acetic acid, can be used with a slight increase in the amount of time needed for removal of fluid loss control pill.
  • [0021]
    The amount of a delayed-release acid breaker of the present invention needed to break the fluid-loss control pill will depend on the composition of the fluid-loss control pill (e.g., the gelling agent, the degree of crosslinking, etc.), the amount of inhibitor present, the temperature of the formation, and other considerations recognized by one skilled in the art with the benefit of this disclosure. Generally speaking, the amount of the breaker to include is an amount sufficient to neutralize any inhibitor that may be present, and reduce the pH of the fluid-loss control pill to a level sufficient to break it. This amount will be determinable by one of ordinary skill in the art with the benefit of this disclosure. In some embodiments, this may be from about 1% to about 10% based on the volume of fluid loss control pill.
  • [0022]
    The orthoesters and/or poly(orthoesters) used in the delayed-release acid breakers of the present invention can have any suitable form. For instance, these compositions can be used in a solution form, a gel form, a solid form, or an emulsion form. In certain applications, a solution form may be useful, e.g., when a faster break of a pill is desired; in other applications, e.g., when a slower break is desirable, a gel or emulsion form may be most suitable. For the solution form, suitable exemplary solvents include propylene glycol, propylene glycol monomethyl ether, dipropylene glycol monomethyl ether, and ethylene glycol monobutyl ether. In some embodiments, mixtures of solvents and water may be beneficial, for example, to keep the orthoester solubilized. The gel form of the orthoester composition may be gelled with suitable polymers and/or surfactants. For the emulsion form, suitable emulsifiers include emulsifiers like “WS-44,” which is commercially available from Halliburton Energy Services, Duncan, Okla.
  • [0023]
    To allow the orthoester to hydrolyze to produce an acid, a source of water is needed. The water should be present in an amount of about 2 moles of water for about every 1 mole of orthoester or poly(orthoester) to an excess of water, which may help ensure the solubility of the reaction product of the reaction between the generated acid and the components in the fluid-loss control pill. One of ordinary skill in the art with the benefit of this disclosure will recognize whether a suitable amount of water is present in either the fluid-loss control pill, the well fluid, or otherwise in the well bore for a desired application.
  • [0024]
    The delayed-release acid breakers of the present invention are generally stable at a pH of about 8 or above. To maintain the delay, preferably the pH should be maintained at 8 or above. To maintain this pH, the delayed-release acid breakers or the fluid-loss control pill may comprise an inhibitor. The inhibitor may further delay the generation of the acid from the orthoester of the orthoester composition, and also may neutralize the generated acid during the delay period. Suitable inhibitors include bases. Examples of some preferred inhibitors may include sodium hydroxide, potassium hydroxide, magnesium oxide, magnesium hydroxide, calcium oxide, calcium hydroxide, amines (such as hexamethylenetetramine), sodium carbonate, potassium carobonate, derivatives of these, and combinations of these. In certain embodiments, a small amount of a strong base as opposed to a large amount of a relatively weak base is preferred to achieve the delayed generation of the acid and the neutralization of the generated acid for a desired delay period.
  • [0025]
    Depending on the pH of the fluid-loss control pill base gel (i.e., the pH of the fluid-loss control pill base gel before raising the pH or before crosslinking and/or before adding the breaker), the breaker may need to be incorporated in a certain manner depending on the stability of the breaker to the pH of the base gel. This is because the degradation of orthoesters and poly(orthoesters) is acid-catalyzed. If the fluid-loss base gel has a high pH (e.g., a pH of 8 or greater), then the orthoester breaker can be added directly to the fluid-loss control pill base gel with little risk of negatively impacting the breaker, followed by the inhibitor and a crosslinking agent if desired. Such base gels include those that comprise guar, guar derivatives, hydroxyethyl cellulose, carboxymethylhydroxyethyl celluose, and Halliburton Energy Services' “HMP” pill, which is currently available from Halliburton Energy Services. Optionally, an emulsifying surfactant may be added to keep the hydrophobic orthoester intimately mixed with the base gel. Sometimes, however, the base gel is a relatively hard gel and it may phase separate when mixed with the breaker. Adding the delayed-release acid breaker by way of an emulsion may be useful in such instances. Since orthoesters and poly(orthoesters) are relatively sensitive to acidic pH, if the fluid-loss control pill base gel is acidic (e.g., vinyl phosphonic acid grafted hydroxyethylcellulose pill or guar pill also called K-MAX pill), to effectively incorporate the breaker into the base gel, a procedure should be used to protect the breaker from the base gel while incorporating the breaker into the base gel. In one embodiment, this may be accomplished by making an emulsion of the breaker in water, and adding it simultaneously with a pH increasing inhibitor and suitable crosslinking agent (if desired) to the base gel. In another embodiment, the emulsion may be formed with a breaker, and a crosslinking agent in an aqueous fluid. An inhibitor may be added if desired. In another embodiment, a poly(orthoester) may be synthesized such that it is sufficiently hydrophobic so that it can withstand the low pH without hydrolyzing while it is being incorporated into the base gel, e.g., as a solid or liquid. Simultaneous addition of the delayed-release acid breaker of the present invention and a crosslinking agent when used is preferred because it allows the breaker to be distributed evenly within the base gel; it may be difficult to mix the breaker into an already crosslinked pill. Addition of orthoester to the K-MAX type of pill by first increasing the pH is also difficult because these base gels tend to crosslink on increasing the pH and it becomes very difficult to mix breaker effectively in this crosslinked fluid. So it is much more desirable to add the breaker, crosslinker and inhibitor simultaneously to the base gel.
  • [0026]
    In the emulsion embodiments (e.g., where the fluid-loss control pill base gel has a low pH), the emulsion of the delayed-release acid breaker may be formed with water, a suitable emulsifying surfactant, optionally an inhibitor (e.g., wherein it is desirable to protect the orthoester or poly(orthoester) from degradation during addition to a low pH base gel or when a longer delay time is desired), and optionally a crosslinking agent. An example of a fluid-loss control pill having a pH of about 1 is described in U.S. Pat. No. 5,304,620, the relevant disclosure of which is incorporated herein by reference. Fluid-loss control pills of this type are commercially available under the trade name “K-MAX” from Halliburton Energy Services in Duncan, Okla. If a crosslinking agent is used, the crosslinking agent may help create a basic emulsion, which helps maintain the stability of the orthoester or the poly(orthoester) in the delayed-release acid breaker. The resultant emulsion can be added to the pill at a lower pH such that the delayed-release acid breaker becomes the discontinuous phase and the fluid-loss control pill becomes the continuous phase in a second emulsion. This second emulsion then can be pumped downhole for fluid-loss control. In preferred embodiments, the gelling agent is crosslinked after the emulsion has been added to the fluid-loss control pill. Another advantage of placing the breaker in an emulsion is that the breaker is mixed in the fluid-loss control pill in relatively even fashion (as the discontinuous phase), which allows for a cleaner break of the fluid-loss control pill. Preferably, the first emulsion is basic, e.g., a pH of about 8 or above. To maintain the pH of the emulsion at a desired level, a suitable inhibitor may be added to the emulsion. The concentration of this inhibitor is one of the main factors in determining the desired break time for the pill. The greater the inhibitor concentration, the greater the delay time before breaking the pill.
  • [0027]
    Suitable emulsifying surfactants for use in the emulsification embodiments of this invention include any surfactant which is capable of making an oil in water emulsion, and which does not adversely affect a component of the pill or the breaker. Suitable examples include, but are not limited to, a variety of anionic and nonionic surfactants, as well as other emulsifiers capable of promoting the formation of oil-in-water emulsions. In general, the emulsifier should be relatively hydrophilic, and blends of emulsifiers can be used to achieve the necessary qualities. Nonionic surfactants may have advantages over ionic emulsifiers; they are compatible with a broad pH range and often form more stable emulsions than do ionic emulsifiers. Particularly useful surfactants include the detergents sold under the trademarks Tween™ 20, Tween™ 80, and the phenoxypolyethoxyethanols like Triton X-10™. A most preferred surfactant is Triton X-100 (t-octylphenoxypolyethoxyethanol).
  • [0028]
    To facilitate a better understanding of the present invention, the following examples of certain aspects of some embodiments are given. In no way should the following examples be read to limit, or define, the scope of the invention.
  • EXAMPLES
  • [0029]
    The following procedure was used to incorporate an orthoester breaker into a fluid-loss control pill. First, 1000 mL of 13.5 calcium bromide brine were poured into a blender jar (the brine was 88.07% 14.2 calcium bromide brine and diluted with 11.93% H2O to make up 13.5 calcium bromide brine with a pH of 4.46 (ideal is 4.4)). 100 mL of the above solution was retained for purging and CL-30 processing. The blender was mixed at a 20% blender speed. 48 g of “WG-33” gelling agent, which is available from Halliburton Energy Services, was placed into a plastic beaker and 40 mL of propylene glycol were added to it. The mixture was mixed by hand using a spatula to form a WG-33/glycol dispersion. The WG-33/glycol dispersion was then added to the brine in the blender at a slow stirring rate that was sufficient to mix the components but slow enough that air did not get introduced into the system. The mixing beaker was then purged of the dispersion by rinsing it with 95 mL of retained brine. 10 mL of 20 Be HCl were added to the brine dispersion mixture to form a base gel. The base gel was allowed to hydrate for 1 hour with no shear. 100 mL of the hydrated base gel was removed and tested as indicated in Table 1.
  • [0030]
    To mix a delayed-release acid breaker of the present invention into the base gel, 4 mL of water and 2 mL of “WS-44” emulsifier, available from Halliburton Energy Services, were added to a small beaker. To this solution, 8 mL of TPOF (tripropylorthoformate) were added and the mixture was emulsified by gentle shaking with a spatula. To this emulsion, “CL-30,” a MgO crosslinking agent commercially available from Halliburton Energy Services, Inc. of Duncan, Okla., and NaOH in a small amount of water were added, and the mixture was mixed thoroughly (amounts shown in Table 1). This emulsion was then added to the hydrated gel in a Waring blender and mixed for couple of minutes. The crosslinked gel was then emptied into ajar and allowed to sit at room temperature for 1 hour to make sure it crosslinked fully. The crosslinked pills were placed in an oven at 135 F., and the time of break was observed visually (the break was indicated when a water-thin fluid resulted). The results are listed in Table 1. These steps were repeated at 160 F., and the same procedure for making observations regarding the break were done.
    TABLE 1
    Pill 1 Pill 2 Pill 3 Pill 4
    100 100 100 100
    mL mL mL mL
    Component Vol. Vol. Vol. Vol.
    Breaker - tripropyl 8 mL 8 mL 8 mL 8 mL
    orthoformate
    H2O 4 mL 4 mL 4 mL 4 mL
    O/W emulsifier, WS-44 2 mL 2 mL 2 mL 2 mL
    MgO Crosslinking Agent 0.72 g 0.72 g 0.72 g 0.72 g
    “CL-30,” commercially
    available from
    Halliburton Energy
    Services, Inc.,
    Duncan, OK
    inhibitor - 2M NaOH 0 mL 3 mL 5 mL 7 mL
    Results @135 F.
    Pill Break Time
    1 4 days
    2 7 days
    3 10 days 
    4 Stopped collection of data on the 13th day
    and still no break at this point.
    Results @160 F.
    Pill Break Time
    1 2 days
    2 2 days
    3 3 days
    4 7 days
  • [0031]
    These results indicate, inter alia, that the inhibitor concentration and temperature can affect delay time for the orthoester breaker.
  • [0032]
    Therefore, the present invention is well adapted to attain the ends and advantages mentioned as well as those that are inherent therein. While numerous changes may be made by those skilled in the art, such changes are encompassed within the spirit of this invention as defined by the appended claims. The terms in the claims have their plain, ordinary meaning unless otherwise explicitly and clearly defined by the patentee.
Patent Citations
Cited PatentFiling datePublication dateApplicantTitle
US2238671 *Feb 9, 1940Apr 15, 1941Du PontMethod of treating wells
US2703316 *Jun 5, 1951Mar 1, 1955Du PontPolymers of high melting lactide
US3173484 *Sep 2, 1958Mar 16, 1965Gulf Research Development CoFracturing process employing a heterogeneous propping agent
US3302719 *Jan 25, 1965Feb 7, 1967Union Oil CoMethod for treating subterranean formations
US3364995 *Feb 14, 1966Jan 23, 1968Dow Chemical CoHydraulic fracturing fluid-bearing earth formations
US3366178 *Sep 10, 1965Jan 30, 1968Halliburton CoMethod of fracturing and propping a subterranean formation
US3784585 *Oct 21, 1971Jan 8, 1974American Cyanamid CoWater-degradable resins containing recurring,contiguous,polymerized glycolide units and process for preparing same
US3868998 *May 15, 1974Mar 4, 1975Shell Oil CoSelf-acidifying treating fluid positioning process
US3948672 *Sep 26, 1974Apr 6, 1976Texaco Inc.Permeable cement composition and method
US4068718 *Oct 26, 1976Jan 17, 1978Exxon Production Research CompanyHydraulic fracturing method using sintered bauxite propping agent
US4252421 *Nov 9, 1978Feb 24, 1981John D. McCarryContact lenses with a colored central area
US4261421 *Mar 24, 1980Apr 14, 1981Union Oil Company Of CaliforniaMethod for selectively acidizing the less permeable zones of a high temperature subterranean formation
US4498995 *Jul 1, 1983Feb 12, 1985Judith GockelLost circulation drilling fluid
US4506734 *Sep 7, 1983Mar 26, 1985The Standard Oil CompanyFracturing fluid breaker system which is activated by fracture closure
US4652384 *Aug 30, 1984Mar 24, 1987American Maize-Products CompanyHigh temperature drilling fluid component
US4716964 *Dec 10, 1986Jan 5, 1988Exxon Production Research CompanyUse of degradable ball sealers to seal casing perforations in well treatment fluid diversion
US4797262 *Jun 3, 1987Jan 10, 1989Shell Oil CompanyDownflow fluidized catalytic cracking system
US4809783 *Jan 14, 1988Mar 7, 1989Halliburton ServicesMethod of dissolving organic filter cake
US4817721 *Dec 14, 1987Apr 4, 1989Conoco Inc.Reducing the permeability of a rock formation
US4822500 *Feb 29, 1988Apr 18, 1989Texas United Chemical CorporationSaturated brine well treating fluids and additives therefore
US4894231 *Jul 28, 1987Jan 16, 1990Biomeasure, Inc.Therapeutic agent delivery system
US4982793 *Mar 10, 1989Jan 8, 1991Halliburton CompanyCrosslinkable cellulose derivatives
US4986353 *Sep 14, 1988Jan 22, 1991Conoco Inc.Placement process for oil field chemicals
US4986354 *Sep 14, 1988Jan 22, 1991Conoco Inc.Composition and placement process for oil field chemicals
US4986355 *May 18, 1989Jan 22, 1991Conoco Inc.Process for the preparation of fluid loss additive and gel breaker
US5082056 *Oct 16, 1990Jan 21, 1992Marathon Oil CompanyIn situ reversible crosslinked polymer gel used in hydrocarbon recovery applications
US5295542 *Oct 5, 1992Mar 22, 1994Halliburton CompanyWell gravel packing methods
US5304620 *Jun 16, 1993Apr 19, 1994Halliburton CompanyMethod of crosslinking cellulose and guar derivatives for treating subterranean formations
US5386874 *Nov 8, 1993Feb 7, 1995Halliburton CompanyPerphosphate viscosity breakers in well fracture fluids
US5396957 *Mar 4, 1994Mar 14, 1995Halliburton CompanyWell completions with expandable casing portions
US5402846 *Nov 15, 1993Apr 4, 1995Mobil Oil CorporationUnique method of hydraulic fracturing
US5484881 *Aug 23, 1993Jan 16, 1996Cargill, Inc.Melt-stable amorphous lactide polymer film and process for manufacturing thereof
US5487897 *Sep 28, 1993Jan 30, 1996Atrix Laboratories, Inc.Biodegradable implant precursor
US5496557 *Jan 30, 1991Mar 5, 1996Akzo N.V.Article for the controlled delivery of an active substance, comprising a hollow space fully enclosed by a wall and filled in full or in part with one or more active substances
US5497830 *Apr 6, 1995Mar 12, 1996Bj Services CompanyCoated breaker for crosslinked acid
US5499678 *Aug 2, 1994Mar 19, 1996Halliburton CompanyCoplanar angular jetting head for well perforating
US5505787 *Jan 28, 1994Apr 9, 1996Total Service Co., Inc.Method for cleaning surface of external wall of building
US5512071 *Feb 25, 1994Apr 30, 1996Church & Dwight Co., Inc.Water soluble blast media containing surfactant
US5591700 *Dec 22, 1994Jan 7, 1997Halliburton CompanyFracturing fluid with encapsulated breaker
US5594095 *Jul 27, 1994Jan 14, 1997Cargill, IncorporatedViscosity-modified lactide polymer composition and process for manufacture thereof
US5604186 *Feb 15, 1995Feb 18, 1997Halliburton CompanyEncapsulated enzyme breaker and method for use in treating subterranean formations
US5607905 *Mar 15, 1994Mar 4, 1997Texas United Chemical Company, Llc.Well drilling and servicing fluids which deposit an easily removable filter cake
US5893416 *Nov 28, 1997Apr 13, 1999Aea Technology PlcOil well treatment
US6024170 *Jun 3, 1998Feb 15, 2000Halliburton Energy Services, Inc.Methods of treating subterranean formation using borate cross-linking compositions
US6028113 *Sep 27, 1995Feb 22, 2000Sunburst Chemicals, Inc.Solid sanitizers and cleaner disinfectants
US6047772 *Nov 9, 1998Apr 11, 2000Halliburton Energy Services, Inc.Control of particulate flowback in subterranean wells
US6169058 *Jun 5, 1997Jan 2, 2001Bj Services CompanyCompositions and methods for hydraulic fracturing
US6172011 *Mar 8, 1996Jan 9, 2001Schlumberger Technolgy CorporationControl of particulate flowback in subterranean wells
US6180571 *Jul 28, 1997Jan 30, 2001Monsanto CompanyFluid loss control additives and subterranean treatment fluids containing the same
US6189615 *Dec 15, 1998Feb 20, 2001Marathon Oil CompanyApplication of a stabilized polymer gel to an alkaline treatment region for improved hydrocarbon recovery
US6202751 *Jul 28, 2000Mar 20, 2001Halliburton Energy Sevices, Inc.Methods and compositions for forming permeable cement sand screens in well bores
US6209643 *Mar 6, 2000Apr 3, 2001Halliburton Energy Services, Inc.Method of controlling particulate flowback in subterranean wells and introducing treatment chemicals
US6209646 *Apr 21, 1999Apr 3, 2001Halliburton Energy Services, Inc.Controlling the release of chemical additives in well treating fluids
US6214773 *Sep 29, 1999Apr 10, 2001Halliburton Energy Services, Inc.High temperature, low residue well treating fluids and methods
US6357527 *May 5, 2000Mar 19, 2002Halliburton Energy Services, Inc.Encapsulated breakers and method for use in treating subterranean formations
US6364945 *Dec 13, 2000Apr 2, 2002Halliburton Energy Services, Inc.Methods and compositions for forming permeable cement sand screens in well bores
US6380138 *Nov 22, 1999Apr 30, 2002Fairmount Minerals Ltd.Injection molded degradable casing perforation ball sealers fluid loss additive and method of use
US6508305 *Sep 14, 2000Jan 21, 2003Bj Services CompanyCompositions and methods for cementing using elastic particles
US6509301 *Aug 25, 2000Jan 21, 2003Daniel Patrick VollmerWell treatment fluids and methods for the use thereof
US6527051 *Jul 12, 2002Mar 4, 2003Halliburton Energy Services, Inc.Encapsulated chemicals for use in controlled time release applications and methods
US6554071 *Jul 12, 2002Apr 29, 2003Halliburton Energy Services, Inc.Encapsulated chemicals for use in controlled time release applications and methods
US6681856 *May 16, 2003Jan 27, 2004Halliburton Energy Services, Inc.Methods of cementing in subterranean zones penetrated by well bores using biodegradable dispersants
US6686328 *Jul 9, 1999Feb 3, 2004The Procter & Gamble CompanyDetergent tablet
US6691780 *Apr 18, 2002Feb 17, 2004Halliburton Energy Services, Inc.Tracking of particulate flowback in subterranean wells
US6702023 *Mar 7, 2000Mar 9, 2004Cleansorb LimitedMethod for treatment of underground reservoirs
US6710019 *Jul 16, 1999Mar 23, 2004Christopher Alan SawdonWellbore fluid
US6837309 *Aug 8, 2002Jan 4, 2005Schlumberger Technology CorporationMethods and fluid compositions designed to cause tip screenouts
US6997259 *Sep 5, 2003Feb 14, 2006Halliburton Energy Services, Inc.Methods for forming a permeable and stable mass in a subterranean formation
US7021337 *Feb 24, 2005Apr 4, 2006Markham Allen RPlumbing test plug and method
US7032663 *Jun 27, 2003Apr 25, 2006Halliburton Energy Services, Inc.Permeable cement and sand control methods utilizing permeable cement in subterranean well bores
US7156174 *Jan 30, 2004Jan 2, 2007Halliburton Energy Services, Inc.Contained micro-particles for use in well bore operations
US7165617 *Jul 27, 2004Jan 23, 2007Halliburton Energy Services, Inc.Viscosified treatment fluids and associated methods of use
US7168489 *Feb 24, 2004Jan 30, 2007Halliburton Energy Services, Inc.Orthoester compositions and methods for reducing the viscosified treatment fluids
US7172022 *Mar 17, 2004Feb 6, 2007Halliburton Energy Services, Inc.Cement compositions containing degradable materials and methods of cementing in subterranean formations
US7178596 *Sep 20, 2004Feb 20, 2007Halliburton Energy Services, Inc.Methods for improving proppant pack permeability and fracture conductivity in a subterranean well
US7195068 *Dec 15, 2003Mar 27, 2007Halliburton Energy Services, Inc.Filter cake degradation compositions and methods of use in subterranean operations
US20020036088 *Jan 9, 2001Mar 28, 2002Todd Bradley L.Well drilling and servicing fluids and methods of removing filter cake deposited thereby
US20030054962 *Jul 15, 2002Mar 20, 2003England Kevin W.Methods for stimulating hydrocarbon production
US20030060374 *Sep 24, 2002Mar 27, 2003Cooke Claude E.Method and materials for hydraulic fracturing of wells
US20040014606 *Mar 25, 2003Jan 22, 2004Schlumberger Technology CorpMethod For Completing Injection Wells
US20040014607 *Jul 16, 2002Jan 22, 2004Sinclair A. RichardDownhole chemical delivery system for oil and gas wells
US20040040706 *Aug 28, 2002Mar 4, 2004Tetra Technologies, Inc.Filter cake removal fluid and method
US20040055747 *Sep 20, 2002Mar 25, 2004M-I Llc.Acid coated sand for gravel pack and filter cake clean-up
US20040070093 *Aug 12, 2003Apr 15, 2004Brown University Research FoundationProcess for preparing microparticles through phase inversion phenomena
US20050006095 *Jul 8, 2003Jan 13, 2005Donald JustusReduced-density proppants and methods of using reduced-density proppants to enhance their transport in well bores and fractures
US20050028976 *Aug 5, 2003Feb 10, 2005Nguyen Philip D.Compositions and methods for controlling the release of chemicals placed on particulates
US20050034861 *Dec 15, 2003Feb 17, 2005Saini Rajesh K.On-the fly coating of acid-releasing degradable material onto a particulate
US20050034865 *Aug 14, 2003Feb 17, 2005Todd Bradley L.Compositions and methods for degrading filter cake
US20050034868 *Jan 7, 2004Feb 17, 2005Frost Keith A.Orthoester compositions and methods of use in subterranean applications
US20050045328 *Feb 24, 2004Mar 3, 2005Frost Keith A.Orthoester compositions and methods for reducing the viscosified treatment fluids
US20050051330 *Sep 5, 2003Mar 10, 2005Nguyen Philip D.Methods for forming a permeable and stable mass in a subterranean formation
US20050056423 *Sep 11, 2003Mar 17, 2005Todd Bradey L.Methods of removing filter cake from well producing zones
US20050059556 *Apr 26, 2004Mar 17, 2005Trinidad MunozTreatment fluids and methods of use in subterranean formations
US20050059557 *Sep 17, 2003Mar 17, 2005Todd Bradley L.Subterranean treatment fluids and methods of treating subterranean formations
US20050059558 *Sep 20, 2004Mar 17, 2005Blauch Matthew E.Methods for improving proppant pack permeability and fracture conductivity in a subterranean well
US20060016596 *Jul 23, 2004Jan 26, 2006Pauls Richard WTreatment fluids and methods of use in subterranean formations
US20060032633 *Aug 10, 2004Feb 16, 2006Nguyen Philip DMethods and compositions for carrier fluids comprising water-absorbent fibers
US20060046938 *Sep 2, 2004Mar 2, 2006Harris Philip CMethods and compositions for delinking crosslinked fluids
US20060065397 *Sep 24, 2004Mar 30, 2006Nguyen Philip DMethods and compositions for inducing tip screenouts in frac-packing operations
Referenced by
Citing PatentFiling datePublication dateApplicantTitle
US7648946Nov 17, 2004Jan 19, 2010Halliburton Energy Services, Inc.Methods of degrading filter cakes in subterranean formations
US7662753May 12, 2005Feb 16, 2010Halliburton Energy Services, Inc.Degradable surfactants and methods for use
US7674753Dec 5, 2006Mar 9, 2010Halliburton Energy Services, Inc.Treatment fluids and methods of forming degradable filter cakes comprising aliphatic polyester and their use in subterranean formations
US7677315Oct 5, 2005Mar 16, 2010Halliburton Energy Services, Inc.Degradable surfactants and methods for use
US7686080Nov 9, 2006Mar 30, 2010Halliburton Energy Services, Inc.Acid-generating fluid loss control additives and associated methods
US7727937Aug 10, 2007Jun 1, 2010Halliburton Energy Services, Inc.Acidic treatment fluids comprising xanthan and associated methods
US7829507Sep 17, 2003Nov 9, 2010Halliburton Energy Services Inc.Subterranean treatment fluids comprising a degradable bridging agent and methods of treating subterranean formations
US7833944Jun 18, 2009Nov 16, 2010Halliburton Energy Services, Inc.Methods and compositions using crosslinked aliphatic polyesters in well bore applications
US7921912 *Aug 10, 2006Apr 12, 2011Halliburton Energy Services, Inc.Non-acid acidizing methods and compositions
US7926568 *Aug 10, 2006Apr 19, 2011Halliburton Energy Services, Inc.Non-acid acidizing methods and compositions
US7998910Feb 24, 2009Aug 16, 2011Halliburton Energy Services, Inc.Treatment fluids comprising relative permeability modifiers and methods of use
US8030249Jan 28, 2005Oct 4, 2011Halliburton Energy Services, Inc.Methods and compositions relating to the hydrolysis of water-hydrolysable materials
US8030251Apr 14, 2010Oct 4, 2011Halliburton Energy Services, Inc.Methods and compositions relating to the hydrolysis of water-hydrolysable materials
US8067343Jul 1, 2008Nov 29, 2011M-I L.L.C.Methods and compositions for preventing high density well completion fluid loss
US8082992Jul 13, 2009Dec 27, 2011Halliburton Energy Services, Inc.Methods of fluid-controlled geometry stimulation
US8329621Apr 6, 2007Dec 11, 2012Halliburton Energy Services, Inc.Degradable particulates and associated methods
US8598092Nov 8, 2007Dec 3, 2013Halliburton Energy Services, Inc.Methods of preparing degradable materials and methods of use in subterranean formations
US8932998 *Oct 5, 2009Jan 13, 2015Baker Hughes IncorporatedMethods for crosslinking water soluble polymers for use in well applications
US9701895 *Nov 22, 2013Jul 11, 2017Halliburton Energy Services, Inc.Dual purpose viscosifier-scale inhibitors for use in subterranean formation operations
US20050059557 *Sep 17, 2003Mar 17, 2005Todd Bradley L.Subterranean treatment fluids and methods of treating subterranean formations
US20060105917 *Nov 17, 2004May 18, 2006Halliburton Energy Services, Inc.In-situ filter cake degradation compositions and methods of use in subterranean formations
US20060105918 *Nov 17, 2004May 18, 2006Halliburton Energy Services, Inc.Methods of degrading filter cakes in subterranean formations
US20060169182 *Jan 28, 2005Aug 3, 2006Halliburton Energy Services, Inc.Methods and compositions relating to the hydrolysis of water-hydrolysable materials
US20060172893 *Jan 28, 2005Aug 3, 2006Halliburton Energy Services, Inc.Methods and compositions relating to the hydrolysis of water-hydrolysable materials
US20060254774 *Oct 5, 2005Nov 16, 2006Halliburton Energy Services, Inc.Degradable surfactants and methods for use
US20060258543 *May 12, 2005Nov 16, 2006Halliburton Energy Services, Inc.Degradable surfactants and methods for use cross-reference to related applications
US20060258544 *May 12, 2005Nov 16, 2006Halliburton Energy Services, Inc.Degradable surfactants and methods for use
US20060276345 *Jun 7, 2005Dec 7, 2006Halliburton Energy Servicers, Inc.Methods controlling the degradation rate of hydrolytically degradable materials
US20070042912 *Aug 16, 2005Feb 22, 2007Halliburton Energy Services, Inc.Delayed tackifying compositions and associated methods involving controlling particulate migration
US20070078063 *Dec 5, 2006Apr 5, 2007Halliburton Energy Services, Inc.Subterranean treatment fluids and methods of treating subterranean formations
US20070078064 *Dec 5, 2006Apr 5, 2007Halliburton Energy Services, Inc.Treatment fluids and methods of forming degradable filter cakes and their use in subterranean formations
US20070173416 *Jan 20, 2006Jul 26, 2007Halliburton Energy Services, Inc.Well treatment compositions for use in acidizing a well
US20070238623 *Mar 30, 2006Oct 11, 2007Halliburton Energy Services, Inc.Degradable particulates as friction reducers for the flow of solid particulates and associated methods of use
US20070281868 *Aug 10, 2007Dec 6, 2007Halliburton Energy Services, Inc.Acidic treatment fluids comprising xanthan and associated methods
US20080026955 *Sep 6, 2007Jan 31, 2008Halliburton Energy Services, Inc.Degradable particulates and associated methods
US20080026959 *Jul 25, 2006Jan 31, 2008Halliburton Energy Services, Inc.Degradable particulates and associated methods
US20080026960 *Sep 15, 2006Jan 31, 2008Halliburton Energy Services, Inc.Degradable particulates and associated methods
US20080035341 *Aug 10, 2006Feb 14, 2008Halliburton Energy Services, Inc.Non-acid acidizing methods and compositions
US20080035342 *Aug 10, 2006Feb 14, 2008Halliburton Energy Services, Inc.Non-acid acidizing methods and compositions
US20080070810 *Nov 8, 2007Mar 20, 2008Halliburton Energy Services, Inc.Methods of preparing degradable materials and methods of use in subterranean formations
US20080139415 *Nov 9, 2006Jun 12, 2008Halliburton Energy Services, Inc.Acid-generating fluid loss control additives and associated methods
US20080217011 *Mar 6, 2007Sep 11, 2008Halliburton Energy Services, Inc.Methods for treating a subterranean formation with a treatment fluid containing a gelling agent and subsequently breaking the gel with an oxidizer
US20090062157 *Aug 30, 2007Mar 5, 2009Halliburton Energy Services, Inc.Methods and compositions related to the degradation of degradable polymers involving dehydrated salts and other associated methods
US20100210486 *Jul 1, 2008Aug 19, 2010M-I L.L.C.Methods and compositions for preventing high density well completion fluid loss
US20100212906 *Feb 20, 2009Aug 26, 2010Halliburton Energy Services, Inc.Method for diversion of hydraulic fracture treatments
US20110082057 *Oct 5, 2009Apr 7, 2011Zhang JinguoMethods for crosslinking water soluble polymers for use in well applications
US20140182854 *Mar 15, 2013Jul 3, 2014Superior Energy Services, L.L.C.Fluid loss control pill with internal breaker and method
US20140318785 *Apr 30, 2013Oct 30, 2014Halliburton Energy Services, Inc.Wellbore Servicing Compositions and Methods of Making and Using Same
CN102311728A *Jul 6, 2010Jan 11, 2012中国石油天然气股份有限公司Chemical pressure-reducing injection-increasing agent for injection well and preparation and use thereof
CN102939307A *Jun 8, 2010Feb 20, 2013陶氏环球技术有限责任公司Particulate water-soluble polymeric polyol treated with trialkyl orthoesters or tetraalkyl orthocarbonates
WO2008107674A1 *Mar 5, 2008Sep 12, 2008Halliburton Energy Services, Inc.Methods for treating a subterranean formation with a treatment fluid containing a gelling agent and subsequently breaking the gel with an oxidizer
WO2009009343A3 *Jul 1, 2008May 7, 2009Mi LlcMethods and compositions for preventing high density well completion fluid loss
WO2011154757A1 *Jun 8, 2010Dec 15, 2011Dow Global Technologies LlcParticulate water-soluble polymeric polyol treated with trialkyl orthoesters or tetraalkyl orthocarbonates
WO2013002755A1 *Jun 27, 2011Jan 3, 2013M-I L.L.C.Breaker fluids for wellbore fluids and methods of use
WO2015020668A1 *Aug 9, 2013Feb 12, 2015Halliburton Energy Services, Inc.Gelling agents with covalently bonded breakers
WO2015076820A1 *Nov 22, 2013May 28, 2015Halliburton Energy Services, Inc.Dual purpose viscosifier-scale inhibitors for use in subterranean formation operations
Classifications
U.S. Classification507/260, 507/103
International ClassificationE21B43/00, C09K8/00
Cooperative ClassificationC09K8/512, C09K8/506, C09K8/514
European ClassificationC09K8/514, C09K8/512, C09K8/506
Legal Events
DateCodeEventDescription
Sep 1, 2005ASAssignment
Owner name: HALLIBURTON ENERGY SERVICES, INC., TEXAS
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SAINI, RAJESH K.;SAVERY, KAREN;REEL/FRAME:016959/0134;SIGNING DATES FROM 20050817 TO 20050822